Treatment of hypercholesterolemia Adults, adolescents and children aged 6 years or older with pure hypercholesterolemia (type IIa including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type IIb) in addition to a diet when the response to diet and other non-pharmacological treatments (exercise, weight loss) is not enough. Adults, adolescents and children aged 6 years or older with homozygous familial hypercholesterolemia, in addition to diet and other lipid-lowering treatments (including LDL apheresis) or when these treatments are not appropriate. Prevention of cardiovascular events Prevention of major cardiovascular events in patients considered at high risk of having a first cardiovascular event (see Pharmacodynamic properties), in addition to the correction of other risk factors.